EUCTR2009-017245-64-GB进行中(未招募)不适用
The effect of metformin co-treatment in hormone-replacement frozen embryo replacement cycles in women with polycystic ovary syndrome. - Metformin in frozen embryo replacement cycles in women with PCOS
eeds Teaching Hospitals NHS Trust0 个研究点目标入组 140 人开始时间: 2010年8月10日最近更新:
适应症
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 进行中(未招募)
- 发起方
- 入组人数
- 140
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- Female
入选标准
- •Women who will be invited to take part in this study would be subject to following inclusion criteria:
- •Women with a known diagnosis of PCOS (as defined by the Rotterdam ESHRE/ASRM sponsored PCOS consensus workshop group, 2004)
- •Women must have cryopreserved embryos created with their own oocytes and be embarking upon their 1st FERC using this cohort of embryos
- •Women must have a normal follicular stimulating hormone (FSH) level, (ref. range 1-8.0iU/L)
- •Women must be 20-39 years of age
- •Women must have a BMI<35
- •Pre-treatment inclusion criteria would include:
- •oSerum testosterone level (< 5.0 nmol/l)
- •oNormal prolactin level (ref. range <600mU/L)
- •oNormal thyroid function test level (TSH ref. range 0.2-6.0 mIU/L)
- •oNormal renal, liver & haematological indices
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) no
- •F.1.3.1 Number of subjects for this age range
排除标准
- •Women who do not conform to the above criteria would be excluded from the study
- •In addition to the above these specific exclusion criteria would apply:
- •Women who have had three or more failed IVF-ET cycles.
- •Women who in previous frozen embryo replacement cycles have demonstrated insufficient endometrial thickening with standard treatment doses of Progynova.
- •Women on other oral-antidiabetic agents or blood-glucose lowering preparations.
- •Women taking phenprocoumon
- •Women taking antivirals such as didanosine, stavudine, tenofovir.
- •Women taking cimetidine
- •Women taking ketofen
- •Women who have radiological examinations using contrast media within the preceding 48 hours.
- •Women with renal or hepatic impairment
- •Women who have had a recent myocardial infarct
- •Women with known vitamin B12 deficiency
研究者
相似试验
招募中
不适用
Study of the effect of Metformin,OC pills versus their combination on thyroid and lipid profile in patients with Polycystic ovary syndromeCTRI/2017/09/009807self
已完成
不适用
Metformin as an adjunct therapy in type 1 diabetesDiabetes 1.Insulin-dependent diabetes mellitusIRCT2016120110988N5Vice Chancellor for research of Tehran University of Medical Sciences29
已完成
2 期
Effects of metformin in the treatment of endometrial hyperplasiaendometrial hyperplasia.Hyperplasia of endometrium: NOS cystic glandular-cystic polypoidIRCT2014082018866N1Tehran University of Medical Sciences64
已完成
2 期
Gastrointestinal mechanisms underlying glucose lowering by metformin in type 2 diabetesType 2 diabetes mellitusMetabolic and Endocrine - DiabetesACTRN12617000243314niversity of Adelaide10
已完成
不适用
The effect of metformin and insulin in the prevention of preeclampsiaPre-eclampsiaIRCT20220107053652N1Esfahan University of Medical Sciences150
